Oregon Clinical and Translational Science Institute

俄勒冈临床与转化科学研究所

• 批准号: 7290121
• 负责人: ERIC S. ORWOLL
• 金额: $ 800.28万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-09-30 至 2011-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7290121
• 关键词: NIH Roadmap Initiative tag; clinical research; cooperative study; health science research support; human subject; interdisciplinary collaboration

Biomedical research institutions in Oregon are outstanding, and are prepared for a major expansion in clinical/translational investigation. We propose to form the Oregon Clinical and Translational Science Institute (OCTSI). The OCTSI will fundamentally change biomedical research to create a vibrant academic home for clinical/translational investigation. It will leverage existing strengths and remove barriers to the pace and growth of research. At the heart of the OCTSI is a robust partnership between Oregon Health & Science University (OHSU) and Kaiser Permanente's Center for Health Research (KPCHR) that brings together a strong biomedical research university and an innovative practice-based research center associated with a large patient population. The collaboration provides unique opportunities for expansion across the spectrum of human investigation, and sets the stage for major advances in human health. Transformation of clinical and translatlonal research in Oregon is enhanced by: 1. Robust institutional support for the OCTSI, manifest by significant administrative change as well as the commitment of substantial financial and space resources 2. Academic faculties at OHSU and KPCHR that fully support the OCTSI initiative and the development of a strong, multidisciplinary OCTSI leadership team 3. Merging of resources to form a coordinated infrastructure for clinical/translational research 4. Strong ties to the community and the involvement of the region in the human research agenda We have identified three major goals for the OCTSI, and propose far-reaching, explicit and feasible approaches to achieve them. We will 1) Create an academic home (the OCTSI) specifically devoted to the discipline of clinical/translational research, 2) Nurture a new cadre of highly-trained, interdisciplinary investigators through a strong, diverse educational curriculum, 3) Create a "Research Commons" - a coordinated infrastructure of core research tools that greatly expands research opportunities and provides a unified, effective means for their access. There are particular opportunities to accelerate progress in pediatric and child health, community based research, and human genetics.

俄勒冈州的生物医学研究机构是杰出的，并为重大扩展做好了准备 临床/翻译研究。我们建议组建俄勒冈州的临床和转化科学学院 （OCTSI）。 OCTSI将从根本上改变生物医学研究，为 临床/翻译研究。它将利用现有的优势并消除对步伐的障碍 研究的增长。 OCTSI的核心是俄勒冈健康与科学之间的强大伙伴关系 大学（OHSU）和Kaiser Permanente的健康研究中心（KPCHR），汇集了一个 强大的生物医学研究大学和与A相关的创新实践研究中心 大量的患者人数。该合作为扩展整个范围提供了独特的机会 人类调查，并为人类健康的重大进展奠定了基础。 俄勒冈州临床和翻译研究的转化通过： 1。对Octsi的强大机构支持，表现出重大的行政变更以及 大量财务和太空资源的承诺 2。OHSU和KPCHR的学术学院，完全支持Octsi倡议和发展 强大的多学科OCTSI领导团队 3。合并资源以形成协调的基础设施进行临床/转化研究 4。与社区的紧密联系以及该地区参与人类研究议程 我们已经确定了OCTSI的三个主要目标，并提出了深远，明确和可行的目标 实现它们的方法。我们将1）创建一个专门致力于的学术房屋（OCTSI） 临床/转化研究学科，2）培养新的训练有素的跨学科的新干部 通过强大，多样化的教育课程进行调查人员，3）创建一个“研究共享” -A 核心研究工具的协调基础设施，可大大扩大研究机会并提供 统一，有效的手段用于他们的访问。 有特殊的机会可以加速儿科和儿童健康的进展，以社区为基础 研究和人类遗传学。